DiaSys launches rapid test portfolio for COVID-19 PRODUCT and Influenza detection
DiaSys has introduced cartridge-based rapid tests for the detection of COVID-19 antigens and IgM and IgG antibodies, Influenza A&B as well as SGTi-flex COVID-19 & Flu A/B Ag DUO. These rapid tests are easy and reliable to use and provide accurate results within a short time. Besides providing quick access to test results, rapid tests increase testing opportunities since no further equipment is required.
SGTi-flex COVID-19 Ag
The new antigen rapid test, SGTi-flex COVID-19 Ag, enables a quick decision whether quarantine is necessary to reduce the spread of the virus or for screening of individuals with an increased risk of exposure (healthcare professionals). The gold nanoparticle-based immunochromatographic rapid test is highly sensitive/specific and easy to perform without any additional equipment. The new rapid test, performed from samples of nasopharyngeal and oropharyngeal swabs, delivers reliable results within 20-30 minutes. For SGTi-flex COVID-19 Ag, DiaSys says they will offer controls in the future as well.
SGTi-flex COVID-19 IgM/IgG
There is an urgent need for reliable antibody detection to analyze the spread of COVID-19. DiaSys offers a rapid test for determination of IgM and IgG antibodies in whole blood (finger-prick blood). The gold nanoparticle-based immunochromatographic rapid test SGTi-flex COVID-19 IgM/IgG, for qualitative detection of antibodies in COVID-19, exhibits high specificity and sensitivity and delivers reliable results within 10-15 minutes.
SGTi-flex Influenza A&B
DiaSys introduces a rapid test for the determination of influenza A and/or B from samples of a nasopharyngeal swab. The SGTi-flex Influenza A&B is a cartridge-based immunochromatographic lateral flow assay providing results within a short time combined with ease of use and safe handling. Clearly separated test lines allow a differentiation between influenza A and/or B virus and indicate as well the validity of each measurement by a control line.
SGTi-flex COVID-19 & Flu A/B Ag DUO
The rapid test portfolio is additionally supported by the SGTi-flex COVID-19 & Flu A/B Ag DUO, a lateral flow immunoassay for the simultaneous qualitative detection of SARS-CoV-2 antigens, Influenza virus type A and or type B antigens directly from nasopharyngeal swab samples. Since both diseases have some similar symptoms, accurate and rapid diagnosis is essential to take effective countermeasures against the different pathogens. With just one sample collection, a differential diagnosis of COVID-19 and influenza A and/or B can be performed within 20 minutes without any additional equipment.
For more information, visit: https://www.diasys-diagnostics.com
